NCT05630950

LDCT-SC-FI Low-dose CT Screening for Lung Cancer

Low-dose CT Screening for Lung Cancer Combined to Different Smoking Cessation Methods in Finland

• Status: Active Not Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Oulu University Hospital · Academic / Other
• Sex: All
• Age: 50 Years – 74 Years
• Healthy volunteers: Accepted

Summary

This is a randomized phase II trial investigating different smoking cessation methods in study subjects undergoing lung cancer screening with low-dose CT (LDCT). The study also evaluates feasibility and outcomes of LDCT screening and potential biomarkers and AI-based evaluation on CT-scans. The study subjects fulfilling I/E-criteria are randomized in 1:1 fashion to yearly LDCT for two rounds with standard smoking cessation (control) or same LDCT approach combined to mobile application based smoking cessation (intervention).

Conditions

• Lung Cancer Screening

Interventions

Type	Name	Description
DEVICE	Smoking cessation mobile application	Mobile application for smoking cessation.
BEHAVIORAL	Written material for smoking cessation	Written material for smoking cessation

Timeline

• Start date: 2022-11-18
• Primary completion: 2026-12-31
• Completion: 2026-12-31
• First posted: 2022-11-30
• Last updated: 2025-08-24

Locations

2 sites across 1 country: Finland